Literature DB >> 6652807

Identification of guanine and adenine adducts in DNA alkylated by dibromodulcitol in vitro and in vivo.

E Institóris, J Tamás.   

Abstract

DNA reacted with dibromodulcitol in neutral solution yielded 3- and 7-alkyl substituted purines after hydrolysis at neutral pH-value at 37 degrees C. The alkylated products were identified by mass spectrometry and by comparison of their UV absorption spectra and chromatographic properties on thin-layer chromatography (TLC) and various columns with those of the corresponding galactitylpurine derivatives obtained by synthetic route from alkylation of the appropriate nucleic bases or nucleosides. The labelled alkylpurines occurring in DNA of Yoshida tumour cells treated with [3H]dibromodulcitol in vivo were also identified by co-chromatography of labelled DNA hydrolysate with synthetic 3- and 7-alkyl substituted purines. On the basis of the same chromatographic behaviour 3-(1-deoxy-3,6-anhydrogalactit-1-yl)adenine, 7-(1-deoxygalactit-1-yl)guanine, 7-(1-deoxy-3,6-anhydrogalactit-1-yl)guanine and 1,6-di(guanin-7-yl)-1,6-dideoxygalactitol were identified as main alkylated products in tumor cell DNA after in vivo treatment with dibromodulcitol.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6652807     DOI: 10.1016/0009-2797(83)90153-9

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  2 in total

1.  Absence of cross-resistance between two alkylating agents: BCNU vs bifunctional galactitol.

Authors:  E Institóris; K Szikla; L Otvös; F Gál
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

2.  The biological activity of cisplatin and dibromodulcitol in combination therapy.

Authors:  A Jeney; I Kovalszky; E Rásó; R E Durand; J Fürész; K Lapis
Journal:  Br J Cancer       Date:  1995-02       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.